Ac Immune Stock Analysis

ACIU Stock Analysis Notes

About 22.0% of the company shares are held by company insiders. The book value of AC Immune was presently reported as 1.3. The company recorded a loss per share of 0.45. AC Immune had not issued any dividends in recent years. AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. The company was incorporated in 2003 and is headquartered in Lausanne, Switzerland. AC Immune operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. For more info on AC Immune please contact Andrea Pfeifer at 41 21 345 91 21 or go to https://www.acimmune.com.

AC Immune Investment Alerts

AC Immune Upcoming and Recent Events

ACIU Largest EPS Surprises

View All Earnings Estimates

AC Immune Environmental, Social, and Governance (ESG) Scores

ACIU Stock Institutional Investors

Note, although AC Immune's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

ACIU Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 337.4 M.

ACIU Profitablity

The company has Profit Margin (PM) of (0.97) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 0.29 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.29.

Management Efficiency

AC Immune has return on total asset (ROA) of (0.1204) % which means that it has lost $0.1204 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.3116) %, meaning that it created substantial loss on money invested by shareholders. AC Immune's management efficiency ratios could be used to measure how well AC Immune manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.43 in 2024. Return On Capital Employed is likely to drop to -0.33 in 2024. Liabilities And Stockholders Equity is likely to gain to about 193.9 M in 2024, whereas Total Current Liabilities is likely to drop slightly above 12.8 M in 2024.

Technical Drivers

As of the 26th of November, AC Immune owns the Market Risk Adjusted Performance of 0.2727, standard deviation of 3.6, and Coefficient Of Variation of 1656.72. AC Immune technical analysis gives you the methodology to make use of past data patterns to determine a pattern that approximates the direction of the entity's future prices.

AC Immune Price Movement Analysis

AC Immune Outstanding Bonds

AC Immune Predictive Daily Indicators

AC Immune Corporate Filings

AC Immune Forecast Models

AC Immune's time-series forecasting models are one of many AC Immune's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary AC Immune's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how AC Immune prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling ACIU shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as AC Immune. By using and applying ACIU Stock analysis, traders can create a robust methodology for identifying ACIU entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. ACIU analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. ACIU analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

AC Immune stock analysis indicators help investors evaluate how AC Immune stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading AC Immune shares will generate the highest return on investment. By understating and applying AC Immune stock analysis, traders can identify AC Immune position entry and exit signals to maximize returns.

When running AC Immune's price analysis, check to measure AC Immune's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AC Immune is operating at the current time. Most of AC Immune's value examination focuses on studying past and present price action to predict the probability of AC Immune's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AC Immune's price. Additionally, you may evaluate how the addition of AC Immune to your portfolios can decrease your overall portfolio volatility.